Showing results (271-280 of 450) with videos related to
Sort By:
Pageof 45
Experimental and Clinical Immunogenetics|January 1, 1985
In vivo reexpression of H-2 antigens in B16 melanoma cellsP L Lollini, M P Colombo, C De Giovanni, et al.Molecular and Cellular Biology|September 1, 1996
HOXB7 constitutively activates basic fibroblast growth factor in melanomasA Caré, A Silvani, E Meccia, et al.International Journal of Cancer|March 15, 1982
Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c miceG Parmiani, M L Sensi, G Carbone, et al.International Journal of Cancer|December 2, 1991
Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactionsM Radrizzani, B Benedetti, C Castelli, et al.Tumori|October 31, 1988
A new procedure for large scale production and freezing of lymphokine activated killer (LAK) cells to be used in adoptive immunotherapy of cancerC Gambacorti-Passerini, M Radrizzani, L Rivoltini, et al.Tumori|December 31, 1987
A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effectsR Marolda, F Belli, A Prada, et al.Journal of Immunogenetics|October 1, 1983
Impaired H-2 expression in B16 melanoma variantsP Nanni, M P Colombo, C De Giovanni, et al.Cancer Research|February 1, 1996
Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cellsM Vagliani, M Rodolfo, F Cavallo, et al.Blood|March 1, 1992
bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cellsD Delia, A Aiello, D Soligo, et al.Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 1, 1995
Mapping of the Hmg1 gene and of seven related sequences in the mouseM Gariboldi, L De Gregorio, S Ferrari, et al.Pageof 45